VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma

Autor: Nadiminti K, Singh Abbi KK, Mott SL, Dozeman L, Tricot A, Schultz A, Behrends S, Zhan F, Tricot G

Publikováno v: OncoTargets and Therapy, Vol Volume 10, Pp 217-226 (2017)

Kalyan Nadiminti,1,2 Kamal Kant Singh Abbi,2,3 Sarah L Mott,2 Lindsay Dozeman,2 Annick Tricot,2 Allyson Schultz,2 Sonya Behrends,2,3 Fenghuang Zhan,2,3 Guido Tricot2,3 1Division of Hematology/Oncology, 2Holden Comprehensive Cancer Center, 3Department

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::04fbe2ca081512718e8ae4f1d62dd8ee
https://www.dovepress.com/vtd-melphalan-is-well-tolerated-and-results-in-very-high-rates-of-stri-peer-reviewed-article-OTT

The Role of Tumor Location on Endoscopic and Surgical Management of Malignant Colon Polyps.

Autor: Weaver L; Department of Surgery, University of Minnesota, Minneapolis, MN, USA., Boatman S; Department of Surgery, University of Minnesota, Minneapolis, MN, USA., Kohn J; Department of Surgery, University of Minnesota, Minneapolis, MN, USA., Mott SL; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA., Gaertner WB; Department of Surgery, University of Minnesota, Minneapolis, MN, USA.; Division of Colon and Rectal Surgery, Department of Surgery, University of Minnesota, Minneapolis, MN, USA., Madoff RD; Department of Surgery, University of Minnesota, Minneapolis, MN, USA.; Division of Colon and Rectal Surgery, Department of Surgery, University of Minnesota, Minneapolis, MN, USA., Melton GB; Department of Surgery, University of Minnesota, Minneapolis, MN, USA.; Division of Colon and Rectal Surgery, Department of Surgery, University of Minnesota, Minneapolis, MN, USA., Shaukat A; Department of Gastroenterology, New York University Langone Health, New York, NY, USA., Hassan I; Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA., Goffredo P; Department of Surgery, University of Minnesota, Minneapolis, MN, USA. goffr002@umn.edu.; Division of Colon and Rectal Surgery, Department of Surgery, University of Minnesota, Minneapolis, MN, USA. goffr002@umn.edu.

Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2024 Oct; Vol. 31 (10), pp. 6452-6460. Date of Electronic Publication: 2024 Jul 30.

Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer.

Autor: Abou Chakra M; Department of Urology, University of Iowa, Iowa City, IA. Electronic address: mabouchakra@uiowa.edu., McElree IM; Carver College of Medicine, University of Iowa, Iowa City, IA., Packiam VT; Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, NJ., Mott SL; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA., O'Donnell MA; Department of Urology, University of Iowa, Iowa City, IA.

Publikováno v: Urologic oncology [Urol Oncol] 2024 Sep; Vol. 42 (9), pp. 289.e13-289.e21. Date of Electronic Publication: 2024 May 24.

Incidence of lymph node metastases in colon cancer: does primary tumor location matter?

Autor: Weaver L; Department of Surgery, University of Minnesota, Minneapolis, Minnesota, United States., Mott SL; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa, United States., Thatipelli S; University of Minnesota Medical School, Minneapolis, Minnesota, United States., Troester A; Department of Surgery, University of Minnesota, Minneapolis, Minnesota, United States., Hassan I; Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States., Shaukat A; Division of Gastroenterology and Hepatology, Department of Medicine, New York University Langone Health, New York, New York, United States., Goffredo P; Division of Colon and Rectal Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minnesota, United States. Electronic address: goffr002@umn.edu.

Publikováno v: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract [J Gastrointest Surg] 2024 Aug; Vol. 28 (8), pp. 1352-1354. Date of Electronic Publication: 2024 May 28.

Phase II study of nab-paclitaxel with gemcitabine for relapsed/refractory small cell lung cancer.

Autor: Byrne MM; Division of Hematology, Oncology, and Blood & Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA, United States., Sutamtewagul G; Division of Hematology, Oncology, and Blood & Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA, United States., Zeitler W; Division of Hematology, Oncology, and Blood & Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA, United States., Mott SL; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States., Zamba GKD; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.; Department of Biostatistics, University of Iowa, Iowa City, IA, United States., Kojadinovic A; Division of Hematology, Oncology, and Blood & Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA, United States., Zhang J; Division of Hematology, Oncology, and Blood & Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA, United States., Abu-Hejleh T; Division of Hematology, Oncology, and Blood & Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA, United States., Clamon G; Division of Hematology, Oncology, and Blood & Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA, United States., Furqan M; Division of Hematology, Oncology, and Blood & Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA, United States.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 Jul 31; Vol. 14, pp. 1303268. Date of Electronic Publication: 2024 Jul 31 (Print Publication: 2024).